Pediatric Kidney Transplant — PeKiT  

End Stage Renal Disease Clinical Trial

Official title: Pediatric Kidney Transplant

Status Recruiting

Clinical Trial Summary

End-stage renal disease (ESRD) is a rare disease in children. Renal transplantation (RT) is the treatment of choice for ESRD in the pediatric population. In France, around 100 pediatric kidney transplants are performed each year. The aim was to evaluate the surgical management of TR and the long-term results.

Clinical Trial Description

End-stage renal disease (ESRD) is a rare pathology in children, whose gold standard treatment is a kidney transplant. In France, around 100 pediatric kidney transplants are performed every year. Although the first adult kidney transplants were performed in 1954, pediatric renal transplantation was considered unsafe compared with dialysis, which was preferred. In the 1980s, improved graft selection, optimized pre-transplant management and a better understanding of the immune system led to the development of pediatric kidney transplantation. Despite considerable progress, graft survival in these long-lived patients remains a major challenge. The aim of this study is to evaluate surgical practices in the four French pediatric transplant centers, and to define risk factors for surgical complications. ;

Related Conditions & MeSH terms

• End Stage Renal Disease
• Kidney Failure, Chronic
• Kidney Transplant; Complications
• Pediatric ALL

• NCT number: NCT05977387
• Study type: Observational
• Source: Imagine Institute
• Contact: Thomas Blanc, Pr
• Phone: + 33 1 44 49 41 86
• Email: thomas.blanc@aphp.fr
• Status: Recruiting
• Start date: October 1, 2021
• Completion date: June 30, 2024